Improving Hepatitis C Treatment in Injection Drug Users

NCT00148031 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Liver Diseases
Drug Abuse
Alcoholism

Interventions

DRUG: Pegylated Interferon and Ribavirin
BEHAVIORAL: Psychosocial
BEHAVIORAL: On-site (MMT Clinic) HCV evaluation and treatment
BEHAVIORAL: Off-site HCV evaluation and treatment

Sponsor

State University of New York - Upstate Medical University